ROG.SW

Equity

ROCHE GS

Health Care · Drug Manufacturers - General

$358.80

+358.80 (+0.00%)

Open

N/A

Day Range

$356.40 - $364.10

52W Range

$231.90 - $374.90

Volume

633K

Price History

Key Statistics

Market Cap

N/A

P/E Ratio

N/A

EPS

N/A

Dividend Yield

N/A

P/B Ratio

N/A

Payout Ratio

N/A

ROE

N/A

Debt/Equity

N/A

Latest News

GCC projects are still moving – but the real test may be what happens next

World Construction Network 2 minutes ago

Market Chatter: Honda Motor to Sell China-Made Electric Vehicles in Japan

MT Newswires 5 minutes ago

Tantalus Extends ERT License Agreement with Itron

MT Newswires 5 minutes ago

Mizuho Securities Adjusts AutoZone Price Target to $3,600 From $3,550, Maintains Neutral Rating

MT Newswires 6 minutes ago

MrBeast Video Editor Fired From Beast Industries Following Kalshi Insider Trading Probe

decrypt 6 minutes ago

Fair Value Estimate

DDM Value

$114.57

213.2% overvalued

Growth: 1.4% | Req. return: 10%

Peers in Health Care

Symbol Name Price Mkt Cap Div Yield Change
ACB Aurora Cannabis Inc. $3.71 N/A - +0.00%
AKBA Akebia Therapeutics, Inc. $1.26 N/A - +0.00%
ABCL AbCellera Biologics Inc. $3.74 N/A - +0.00%
ACAD ACADIA Pharmaceuticals Inc. $22.81 N/A - +0.00%
001540.KQ AHN-GOOK PHA $7,870.00 N/A 5.59% +0.00%
A Agilent Technologies, Inc. $116.88 N/A 0.85% +0.00%
ABBV AbbVie Inc. $234.26 N/A 2.84% +0.00%
ABT Abbott Laboratories $114.12 N/A 2.10% +0.00%

Community Sentiment

Sign in to vote

0% Bullish 0% Neutral 100% Bearish

0 votes

Discussion (0)

Sign in to join the discussion

Loading comments...

About ROCHE GS

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.

www.roche.com →

Dividend Safety

Assessment based on payout ratio, debt levels, profit margins, and dividend growth track record.

60

Safe

Based on 4 fundamental factors

+ 9 years of growth

Analysis Tools

Sign in for analysis tools

Share